Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseCareers Blog By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Clinical ResearchPhase 1 - Phase 4 The Rise of Radiotherapeutics: Brief History and Best Practices for Clinical Trials By Premier Research January 5, 2023 Clinical ResearchPhase 1 - Phase 4 Premier Perspective on Biomarkers in Oncology By Premier Research November 2, 2022 Clinical ResearchPhase 1 - Phase 4 Antibody-Drug Conjugates in Oncology: Key Considerations and Future Trends By Premier Research October 13, 2022 Product Development Navigating Regulatory Pathways for Digital Therapeutics By Premier Research July 27, 2022 Clinical ResearchPhase 1 - Phase 4 Addressing the Top 7 Challenges in Decentralized Dermatology Trials By Premier Research July 13, 2022 Clinical ResearchPhase 1 - Phase 4 Gaining Patient Input: How to Ensure Patient Interests Remain Top of Mind By Premier Research December 15, 2021 Previous 1 2 3 4 … 17 Next × ALSO OF INTERESTUsing the 505(b)(2) Pathway to Streamline...A Fit-for-Purpose Path Forward: Linking RWD to...The Rise of Radiotherapeutics: Brief History...